Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-PREGABALIN APOTEX INC Actual shortage 150MG Updated Report 2024-06-16 216726
TECHNESCAN MAG3 CURIUM CANADA INC Actual shortage 1MG Updated Report 2024-06-15 229736
NITROLINGUAL PUMPSPRAY SANOFI-AVENTIS CANADA INC Resolved 0.4MG Updated Report 2024-06-15 186618
MYCOPHENOLATE MOFETIL FOR INJECTION, USP ACCORD HEALTHCARE INC Actual shortage 500MG Updated Report 2024-06-15 207554
SOLU-MEDROL PFIZER CANADA ULC Resolved 1G Updated Report 2024-06-15 220618
CASPOFUNGIN FOR INJECTION JUNO PHARMACEUTICALS CORP. Actual shortage 70MG Updated Report 2024-06-15 230498
CASPOFUNGIN FOR INJECTION JUNO PHARMACEUTICALS CORP. Actual shortage 50MG Updated Report 2024-06-15 230495
APO-DEXLANSOPRAZOLE APOTEX INC Actual shortage 30MG Updated Report 2024-06-15 230576
APO-DEXLANSOPRAZOLE APOTEX INC Actual shortage 60MG Updated Report 2024-06-15 230579
NYADERM TARO PHARMACEUTICALS INC Actual shortage 100000UNIT New Report 2024-06-14 230685
NYADERM TARO PHARMACEUTICALS INC Actual shortage 100000UNIT New Report 2024-06-14 230682
TARO-LURASIDONE TARO PHARMACEUTICALS INC Actual shortage 120MG New Report 2024-06-14 230679
TARO-LURASIDONE TARO PHARMACEUTICALS INC Actual shortage 60MG Updated Report 2024-06-14 230675
TARO-IMIQUIMOD PUMP TARO PHARMACEUTICALS INC Actual shortage 5% New Report 2024-06-14 230672
TARO-CLOBETASOL CREAM USP, 0.05% TARO PHARMACEUTICALS INC Actual shortage 0.05% New Report 2024-06-14 230669
TARO-GLICLAZIDE MR SUN PHARMA CANADA INC Actual shortage 30MG Updated Report 2024-06-14 215021
TARO-GLICLAZIDE MR SUN PHARMA CANADA INC Actual shortage 60MG Updated Report 2024-06-14 169507
TARO-VENLAFAXINE XR SUN PHARMA CANADA INC Actual shortage 150MG Updated Report 2024-06-14 178205
BREVICON 1/35 TABLETS (21-DAY PACK) PFIZER CANADA ULC Anticipated shortage 0.035MG 1MG Updated Report 2024-06-14 230652
TARO-PREGABALIN SUN PHARMA CANADA INC Actual shortage 50MG Updated Report 2024-06-14 199131

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
FOSRENOL TAKEDA CANADA INC Discontinued 500MG Updated Report 2024-06-10 228178
GLUCONORM 2.0MG NOVO NORDISK CANADA INC To be discontinued 2.0MG Updated Report 2024-06-05 201489
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-06-04 204160
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 100MG New Report 2024-06-04 229623
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 50MG New Report 2024-06-04 229620
SUPREFACT DEPOT 2 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH To be discontinued 6.3MG New Report 2024-06-03 228169
BUPIVACAINE HYDROCHLORIDE INJECTION, USP STERIMAX INC Discontinued 7.5MG Updated Report 2024-06-01 216017
AVAPRO SANOFI-AVENTIS CANADA INC To be discontinued 75MG New Report 2024-05-31 229306
REPATHA AMGEN CANADA INC To be discontinued 120MG Updated Report 2024-05-24 223420
ZOVIRAX GLAXOSMITHKLINE INC Discontinued 200MG New Report 2024-05-24 228728